ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Scopolamine Transdermal Patch - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-19G10308
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Scopolamine Transdermal Patch Market Insights Forecast to 2028
BUY CHAPTERS

Scopolamine Transdermal Patch - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19G10308
Report
November 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Perrigo
Baxter
GSK
Mylan NV
Novartis
BengbuBBCATushan Pharmaceutical Co

Scopolamine Transdermal Patch - Market Size

Global Scopolamine market is projected to reach US$ 15 million in 2029, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029.

Scopolamine Transdermal Patch - Market

Scopolamine Transdermal Patch - Market

Scopolamine is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics. It works by blocking the effects of a certain natural substance (acetylcholine) on the central nervous system.
The global market for Scopolamine Transdermal Patch was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Demand from Tablets and Injection are the major drivers for the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Scopolamine Transdermal Patch, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Scopolamine Transdermal Patch by region & country, by Type, and by Application.
The Scopolamine Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine Transdermal Patch.
Market Segmentation

Scope of Scopolamine Transdermal Patch - Market Report

Report Metric Details
Report Name Scopolamine Transdermal Patch - Market
Accounted market size in 2022 US$ 11 million
Forecasted market size in 2029 US$ 15 million
CAGR 4.2%
Base Year 2022
Forecasted years 2024 - 2029
Segment by Type:
  • 1mg
  • 1.5mg
Segment by Application
  • Motion Sickness
  • Nausea/Vomiting
  • Parkinsonian Tremor
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Perrigo, Baxter, GSK, Mylan, Novartis, BengbuBBCATushan Pharmaceutical Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Scopolamine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Scopolamine Transdermal Patch in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

How fast is Scopolamine Transdermal Patch - Market growing?

Ans: The Scopolamine Transdermal Patch - Market witnessing a CAGR of 4.2% during the forecast period 2024-2029.

What is the Scopolamine Transdermal Patch - Market size in 2029?

Ans: The Scopolamine Transdermal Patch - Market size in 2029 will be US$ 15 million.

Who are the main players in the Scopolamine Transdermal Patch - Market report?

Ans: The main players in the Scopolamine Transdermal Patch - Market are Perrigo, Baxter, GSK, Mylan, Novartis, BengbuBBCATushan Pharmaceutical Co

What are the Application segmentation covered in the Scopolamine Transdermal Patch - Market report?

Ans: The Applications covered in the Scopolamine Transdermal Patch - Market report are Motion Sickness, Nausea/Vomiting, Parkinsonian Tremor, Others

What are the Type segmentation covered in the Scopolamine Transdermal Patch - Market report?

Ans: The Types covered in the Scopolamine Transdermal Patch - Market report are 1mg, 1.5mg

1 Market Overview
1.1 Scopolamine Transdermal Patch Product Introduction
1.2 Global Scopolamine Transdermal Patch Market Size Forecast
1.2.1 Global Scopolamine Transdermal Patch Sales Value (2019-2030)
1.2.2 Global Scopolamine Transdermal Patch Sales Volume (2019-2030)
1.2.3 Global Scopolamine Transdermal Patch Sales Price (2019-2030)
1.3 Scopolamine Transdermal Patch Market Trends & Drivers
1.3.1 Scopolamine Transdermal Patch Industry Trends
1.3.2 Scopolamine Transdermal Patch Market Drivers & Opportunity
1.3.3 Scopolamine Transdermal Patch Market Challenges
1.3.4 Scopolamine Transdermal Patch Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Scopolamine Transdermal Patch Players Revenue Ranking (2023)
2.2 Global Scopolamine Transdermal Patch Revenue by Company (2019-2024)
2.3 Global Scopolamine Transdermal Patch Players Sales Volume Ranking (2023)
2.4 Global Scopolamine Transdermal Patch Sales Volume by Company Players (2019-2024)
2.5 Global Scopolamine Transdermal Patch Average Price by Company (2019-2024)
2.6 Key Manufacturers Scopolamine Transdermal Patch Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Scopolamine Transdermal Patch Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Scopolamine Transdermal Patch
2.9 Scopolamine Transdermal Patch Market Competitive Analysis
2.9.1 Scopolamine Transdermal Patch Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Scopolamine Transdermal Patch Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Transdermal Patch as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 1mg
3.1.2 1.5mg
3.2 Global Scopolamine Transdermal Patch Sales Value by Type
3.2.1 Global Scopolamine Transdermal Patch Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Scopolamine Transdermal Patch Sales Value, by Type (2019-2030)
3.2.3 Global Scopolamine Transdermal Patch Sales Value, by Type (%) (2019-2030)
3.3 Global Scopolamine Transdermal Patch Sales Volume by Type
3.3.1 Global Scopolamine Transdermal Patch Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Scopolamine Transdermal Patch Sales Volume, by Type (2019-2030)
3.3.3 Global Scopolamine Transdermal Patch Sales Volume, by Type (%) (2019-2030)
3.4 Global Scopolamine Transdermal Patch Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Motion Sickness
4.1.2 Nausea/Vomiting
4.1.3 Parkinsonian Tremor
4.1.4 Others
4.2 Global Scopolamine Transdermal Patch Sales Value by Application
4.2.1 Global Scopolamine Transdermal Patch Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Scopolamine Transdermal Patch Sales Value, by Application (2019-2030)
4.2.3 Global Scopolamine Transdermal Patch Sales Value, by Application (%) (2019-2030)
4.3 Global Scopolamine Transdermal Patch Sales Volume by Application
4.3.1 Global Scopolamine Transdermal Patch Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Scopolamine Transdermal Patch Sales Volume, by Application (2019-2030)
4.3.3 Global Scopolamine Transdermal Patch Sales Volume, by Application (%) (2019-2030)
4.4 Global Scopolamine Transdermal Patch Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Scopolamine Transdermal Patch Sales Value by Region
5.1.1 Global Scopolamine Transdermal Patch Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Scopolamine Transdermal Patch Sales Value by Region (2019-2024)
5.1.3 Global Scopolamine Transdermal Patch Sales Value by Region (2025-2030)
5.1.4 Global Scopolamine Transdermal Patch Sales Value by Region (%), (2019-2030)
5.2 Global Scopolamine Transdermal Patch Sales Volume by Region
5.2.1 Global Scopolamine Transdermal Patch Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Scopolamine Transdermal Patch Sales Volume by Region (2019-2024)
5.2.3 Global Scopolamine Transdermal Patch Sales Volume by Region (2025-2030)
5.2.4 Global Scopolamine Transdermal Patch Sales Volume by Region (%), (2019-2030)
5.3 Global Scopolamine Transdermal Patch Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Scopolamine Transdermal Patch Sales Value, 2019-2030
5.4.2 North America Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Scopolamine Transdermal Patch Sales Value, 2019-2030
5.5.2 Europe Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Scopolamine Transdermal Patch Sales Value, 2019-2030
5.6.2 Asia Pacific Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Scopolamine Transdermal Patch Sales Value, 2019-2030
5.7.2 South America Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Scopolamine Transdermal Patch Sales Value, 2019-2030
5.8.2 Middle East & Africa Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Scopolamine Transdermal Patch Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Scopolamine Transdermal Patch Sales Value
6.2.1 Key Countries/Regions Scopolamine Transdermal Patch Sales Value, 2019-2030
6.2.2 Key Countries/Regions Scopolamine Transdermal Patch Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Scopolamine Transdermal Patch Sales Value, 2019-2030
6.3.2 United States Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Scopolamine Transdermal Patch Sales Value, 2019-2030
6.4.2 Europe Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Scopolamine Transdermal Patch Sales Value, 2019-2030
6.5.2 China Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.5.3 China Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Scopolamine Transdermal Patch Sales Value, 2019-2030
6.6.2 Japan Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Scopolamine Transdermal Patch Sales Value, 2019-2030
6.7.2 South Korea Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Scopolamine Transdermal Patch Sales Value, 2019-2030
6.8.2 Southeast Asia Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Scopolamine Transdermal Patch Sales Value, 2019-2030
6.9.2 India Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
6.9.3 India Scopolamine Transdermal Patch Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Perrigo
7.1.1 Perrigo Company Information
7.1.2 Perrigo Introduction and Business Overview
7.1.3 Perrigo Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Perrigo Scopolamine Transdermal Patch Product Offerings
7.1.5 Perrigo Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Scopolamine Transdermal Patch Product Offerings
7.2.5 Baxter Recent Development
7.3 GSK
7.3.1 GSK Company Information
7.3.2 GSK Introduction and Business Overview
7.3.3 GSK Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
7.3.4 GSK Scopolamine Transdermal Patch Product Offerings
7.3.5 GSK Recent Development
7.4 Mylan
7.4.1 Mylan Company Information
7.4.2 Mylan Introduction and Business Overview
7.4.3 Mylan Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Mylan Scopolamine Transdermal Patch Product Offerings
7.4.5 Mylan Recent Development
7.5 Novartis
7.5.1 Novartis Company Information
7.5.2 Novartis Introduction and Business Overview
7.5.3 Novartis Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Scopolamine Transdermal Patch Product Offerings
7.5.5 Novartis Recent Development
7.6 BengbuBBCATushan Pharmaceutical Co
7.6.1 BengbuBBCATushan Pharmaceutical Co Company Information
7.6.2 BengbuBBCATushan Pharmaceutical Co Introduction and Business Overview
7.6.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Offerings
7.6.5 BengbuBBCATushan Pharmaceutical Co Recent Development
8 Industry Chain Analysis
8.1 Scopolamine Transdermal Patch Industrial Chain
8.2 Scopolamine Transdermal Patch Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Scopolamine Transdermal Patch Sales Model
8.5.2 Sales Channel
8.5.3 Scopolamine Transdermal Patch Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Perrigo
Baxter
GSK
Mylan NV
Novartis
BengbuBBCATushan Pharmaceutical Co
List of Tables
    Table 1. Scopolamine Transdermal Patch Market Trends
    Table 2. Scopolamine Transdermal Patch Market Drivers & Opportunity
    Table 3. Scopolamine Transdermal Patch Market Challenges
    Table 4. Scopolamine Transdermal Patch Market Restraints
    Table 5. Global Scopolamine Transdermal Patch Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Scopolamine Transdermal Patch Revenue Market Share by Company (2019-2024)
    Table 7. Global Scopolamine Transdermal Patch Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Scopolamine Transdermal Patch Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Scopolamine Transdermal Patch Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Scopolamine Transdermal Patch Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Scopolamine Transdermal Patch Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Scopolamine Transdermal Patch
    Table 13. Global Scopolamine Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Transdermal Patch as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Scopolamine Transdermal Patch Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Scopolamine Transdermal Patch Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Scopolamine Transdermal Patch Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Scopolamine Transdermal Patch Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Scopolamine Transdermal Patch Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Scopolamine Transdermal Patch Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Scopolamine Transdermal Patch Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Scopolamine Transdermal Patch Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Scopolamine Transdermal Patch Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Scopolamine Transdermal Patch Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Scopolamine Transdermal Patch Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Scopolamine Transdermal Patch Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Scopolamine Transdermal Patch Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Scopolamine Transdermal Patch Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Scopolamine Transdermal Patch Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Scopolamine Transdermal Patch Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Scopolamine Transdermal Patch Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Scopolamine Transdermal Patch Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Scopolamine Transdermal Patch Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Scopolamine Transdermal Patch Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Scopolamine Transdermal Patch Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Scopolamine Transdermal Patch Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Scopolamine Transdermal Patch Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Scopolamine Transdermal Patch Sales Value by Region (2019-2024) & (%)
    Table 44. Global Scopolamine Transdermal Patch Sales Value by Region (2025-2030) & (%)
    Table 45. Global Scopolamine Transdermal Patch Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Scopolamine Transdermal Patch Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Scopolamine Transdermal Patch Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Scopolamine Transdermal Patch Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Scopolamine Transdermal Patch Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Scopolamine Transdermal Patch Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Scopolamine Transdermal Patch Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Scopolamine Transdermal Patch Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Scopolamine Transdermal Patch Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Scopolamine Transdermal Patch Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Scopolamine Transdermal Patch Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Scopolamine Transdermal Patch Sales Volume, (2025-2030) & (K Units)
    Table 57. Perrigo Company Information
    Table 58. Perrigo Introduction and Business Overview
    Table 59. Perrigo Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Perrigo Scopolamine Transdermal Patch Product Offerings
    Table 61. Perrigo Recent Development
    Table 62. Baxter Company Information
    Table 63. Baxter Introduction and Business Overview
    Table 64. Baxter Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Baxter Scopolamine Transdermal Patch Product Offerings
    Table 66. Baxter Recent Development
    Table 67. GSK Company Information
    Table 68. GSK Introduction and Business Overview
    Table 69. GSK Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. GSK Scopolamine Transdermal Patch Product Offerings
    Table 71. GSK Recent Development
    Table 72. Mylan Company Information
    Table 73. Mylan Introduction and Business Overview
    Table 74. Mylan Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Mylan Scopolamine Transdermal Patch Product Offerings
    Table 76. Mylan Recent Development
    Table 77. Novartis Company Information
    Table 78. Novartis Introduction and Business Overview
    Table 79. Novartis Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Novartis Scopolamine Transdermal Patch Product Offerings
    Table 81. Novartis Recent Development
    Table 82. BengbuBBCATushan Pharmaceutical Co Company Information
    Table 83. BengbuBBCATushan Pharmaceutical Co Introduction and Business Overview
    Table 84. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Offerings
    Table 86. BengbuBBCATushan Pharmaceutical Co Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Scopolamine Transdermal Patch Downstream Customers
    Table 90. Scopolamine Transdermal Patch Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Scopolamine Transdermal Patch Product Picture
    Figure 2. Global Scopolamine Transdermal Patch Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Scopolamine Transdermal Patch Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Scopolamine Transdermal Patch Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Scopolamine Transdermal Patch Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Scopolamine Transdermal Patch Report Years Considered
    Figure 7. Global Scopolamine Transdermal Patch Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Scopolamine Transdermal Patch Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Scopolamine Transdermal Patch Revenue in 2023
    Figure 10. Scopolamine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 1mg Picture
    Figure 12. 1.5mg Picture
    Figure 13. Global Scopolamine Transdermal Patch Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Scopolamine Transdermal Patch Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Scopolamine Transdermal Patch Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Scopolamine Transdermal Patch Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Scopolamine Transdermal Patch Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Motion Sickness
    Figure 19. Product Picture of Nausea/Vomiting
    Figure 20. Product Picture of Parkinsonian Tremor
    Figure 21. Product Picture of Others
    Figure 22. Global Scopolamine Transdermal Patch Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Scopolamine Transdermal Patch Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Scopolamine Transdermal Patch Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Scopolamine Transdermal Patch Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Scopolamine Transdermal Patch Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Scopolamine Transdermal Patch Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Scopolamine Transdermal Patch Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Scopolamine Transdermal Patch Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Scopolamine Transdermal Patch Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Scopolamine Transdermal Patch Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Scopolamine Transdermal Patch Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Scopolamine Transdermal Patch Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Scopolamine Transdermal Patch Sales Volume (%), (2019-2030)
    Figure 39. United States Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Scopolamine Transdermal Patch Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Scopolamine Transdermal Patch Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Scopolamine Transdermal Patch Sales Value by Application (%), 2023 VS 2030
    Figure 60. Scopolamine Transdermal Patch Industrial Chain
    Figure 61. Scopolamine Transdermal Patch Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Scopolamine Transdermal Patch - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19G10308
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Anticoagulant Rodenticides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Y9321
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Urinary Incontinence Assist Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30K8474
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Chemotherapy Intravenous Infusion Pump - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31O13992
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions